Anti-inflammatory drug celecoxib reacts with protein and induces liver cancer cells to commit suicide The anti-inflammatory drug celecoxib, known by the brand name Celebrex, triggers liver cancer cell death by reacting with a protein in a way that makes those cells commit suicide, according to a fresh study. Researchers also found that the combination of celecoxib with each of two chemotherapy medicines killed more liver tumor cells in tradition, making those combinations far better than either drug on its own treatments . Each chemotherapy drug by itself will reduce the growth of cancer cells, but when each single drug is combined with Celebrex, a greater growth suppression impact was noticed, said Jiayuh Lin, senior author of the study and a co-employee professor of pediatrics at Ohio State University.
Antiepileptic drug Levetiracetam can help patients with Parkinson’s disease In patients with Parkinson’s disease, the antiepileptic medication levetiracetam ) decreased the involuntary movements connected with levodopa, the medication mostly used to treat Parkinson’s disease, according to a study presented today at the 56th annual meeting of the American Academy of Neurology. The independent study is among the first to particularly evaluate an antiepileptic medication for the treatment of levodopa-induced dyskinesia in Parkinson’s patients. ‘Levodopa-induced dyskinesia remains one of the primary challenges in dealing with Parkinson’s disease since it is a common side-effect and is difficult to manage,’ said business lead investigator Theresa Zesiewicz, M.D., assistant director of the Parkinson’s Disease and Movement Disorders Center, and associate professor of neurology at the University of South Florida.